Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...

Ad-blockers and privacy-focused browser protections are eroding business analytics at the precise moment when organizations must sharpen their understanding of user behav­ior to remain competitive.

Cofense, a leader in intelligence-driven phishing defense, is enhancing its portfolio, introducing Smart Reinforcement within its Security Awareness Training solution, and unveiling the latest release ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Our panel looks at whether smartwatch makers blew it by not focusing on the enterprise, why intent-based networking is the next big thing, whether GPS spoofing is real, and how high is too high when ...